Home › Parkinson's Disease › NCT06857851
Optimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Parkinson's disease with bilateral STN DBS * Availability of pre-operative MR images (with a T1-weighted, gradient-echo sequence) and ability to get post-operative MRI or CT scans * Hoehn and Yahr stage 2-4 when off medication, and a stable antiparkinsonian medication regimen and DBS parameter settings Exclusion Criteria: * Previous surgical therapy for Parkinson's disease (other than DBS) * Dementia * Clinically significant untreated depression or anxiety * Clinical features suggestive of atypical parkinsonism
About the study
Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment and strabismus, frequently affects the quality of life in patients with Parkinson's disease. The investigators study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence and strabismus by integrating the patient-specific deep brain stimulation models and high-resolution eye-tracking measures. The knowledge gained will allow the investigators to find the most beneficial stimulation location and parameters for improving binocular coordination, strabismus, and vergence while preserving the ability to treat motor symptoms in Parkinson's disease.
Sponsor: VA Office of Research and Development · Participants: 80 · Started: Feb 1, 2026
Contact the study team
- Aasef G Shaikh, MD PhD · Phone: (216) 791-3800
- Cheryl Dudek · Phone: (216) 679-3800
Official record on ClinicalTrials.gov — NCT06857851
Locations in the U.S.
| Ohio | Louis Stokes VA Medical Center, Cleveland, OH, Cleveland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.